Sanofi Invests Eight Hundred Million Euros in New Vaccine Manufacturing Facility in France
Sanofi will build an advanced messenger RNA vaccine plant in the Auvergne-Rhone-Alpes region as France seeks to strengthen domestic pharmaceutical production capacity for future health emergencies.